Green Cross LabCell, a South Korea-based biopharmaceutical company, announced it will begin development of a COVID-19 treatment based on its anticancer therapy work using natural killer cells. Human clinical trials for the treatment are expected to begin in the second half of this year in the U.S. and South […]
